Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
United Laboratories International Holdings OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
United Laboratories International Holdings OCF Yield % Related Terms
United Laboratories International Holdings OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
United Laboratories International Holdings OCF Yield % Chart
United Laboratories International Holdings Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
United Laboratories International Holdings OCF Yield % vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
United Laboratories International Holdings (FRA:UNJ) has a OCF Yield % of 22.90 as of Jul. 16, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on United Laboratories International Holdings and its competitors. This is 35% above median its historical median of 16.91. Over the past decade, United Laboratories International Holdings' OCF Yield % has ranged from 6.00 to 37.19. According to the industry distribution chart, United Laboratories International Holdings ranks #65 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 6.5%.
Is United Laboratories International Holdings' OCF Yield % too high?
United Laboratories International Holdings' current OCF Yield % of 22.90 is 35% above median its 10-year median of 16.91. Over the past 10 years, this metric has ranged from a low of 6.00 to a high of 37.19. The Drug Manufacturers industry median OCF Yield % is 3.39. United Laboratories International Holdings' value of 22.90 is 575.5% above this industry median. Based on the distribution chart, United Laboratories International Holdings ranks #65 out of 1007 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, United Laboratories International Holdings has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does United Laboratories International Holdings' OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, United Laboratories International Holdings ranks #65 out of 1007 companies for OCF Yield %. This places United Laboratories International Holdings in the top 7% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.39. United Laboratories International Holdings' value of 22.90 is 575.5% above this benchmark. Historically, United Laboratories International Holdings' own OCF Yield % has ranged from 6.00 to 37.19 over the past decade. While the company's 10-year median is 16.91 vs. the industry median of 3.39, United Laboratories International Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.39, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. United Laboratories International Holdings's current OCF Yield % of 22.90 is 575.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on United Laboratories International Holdings and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. United Laboratories International Holdings's current OCF Yield % is 22.90, which is 35% above median its own 10-year median of 16.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Laboratories International Holdings stock overvalued right now?
United Laboratories International Holdings (FRA:UNJ) has a current OCF Yield % of 22.90. The stock's GF Value™ is €0.96, compared to a current price of €1.00 — trading 4.2% above its estimated fair value. The current OCF Yield % is 22.90, which is 35% above median its 10-year median of 16.91 and 575.5% above the Drug Manufacturers industry median of 3.39. United Laboratories International Holdings' overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For United Laboratories International Holdings (FRA:UNJ), the current OCF Yield % is 22.90 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is United Laboratories International Holdings (FRA:UNJ) Overvalued in 2026?
Based on GuruFocus' analysis, United Laboratories International Holdings stock appears to be overvalued.
The current stock price of €1.00 is trading 4.2% above its estimated GF Value™ of €0.96.
Key valuation signals for FRA:UNJ:
OCF Yield %: 22.90 (35% above median its 10-year median of 16.91)
GF Value™: €0.96 vs. price of €1.00 (4.2% above fair value)
Industry Position: 575.5% above the Drug Manufacturers median (#65 of 1007)
No single metric tells the full story. See the FRA:UNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
United Laboratories International Holdings Business Description
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
85GF Score
Get the complete analysis for FRA:UNJ
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:UNJ has been successfully added to your 
